Banmédica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was CLP 1,703,558.76 million compared to CLP 1,519,353.95 million a year ago. Net loss was CLP 8,897.61 million compared to CLP 3,443.56 million a year ago. Basic loss per share from continuing operations was CLP 11.06 compared to CLP 4.28 a year ago.